HC Wainwright Begins Coverage on Evaxion Biotech A/S (NASDAQ:EVAX)

HC Wainwright began coverage on shares of Evaxion Biotech A/S (NASDAQ:EVAX – Free Report) in a report published on Monday, MarketBeat reports. The brokerage issued a buy rating and a $14.00 price target on the stock. HC Wainwright also issued estimates for Evaxion Biotech A/S’s FY2023 earnings at ($6.90) EPS, FY2024 earnings at ($0.10) EPS, […]

Related Keywords

,Jpmorgan Chase Co ,Beacon Capital Management ,Elm Advisors ,Ae Wealth Management ,Susquehanna International Group ,Evaxion Biotech ,Free Report ,Get Free Report ,International Group ,Capital Management ,Evaxion Biotecha S ,Nasdaq Evax ,Devax ,Medical ,Initiated Coverage ,Hc Wainwright ,